# SCN8A

## Overview
The SCN8A gene encodes the sodium voltage-gated channel alpha subunit 8, commonly referred to as NaV1.6, which is a critical transmembrane protein involved in the regulation of neuronal excitability. NaV1.6 is a member of the voltage-gated sodium channel family and plays a pivotal role in the initiation and propagation of action potentials in neurons. It is predominantly expressed in the central and peripheral nervous systems, particularly at nodes of Ranvier and the axon initial segment, where it facilitates rapid sodium ion influx essential for electrical signaling (Caldwell2000Sodium). The channel's structure, characterized by four homologous domains with six transmembrane segments each, allows it to function as a selective ion channel, crucial for maintaining neuronal communication and synaptic plasticity (Jiang2022Structural). Mutations in SCN8A have been linked to a spectrum of neurological disorders, including developmental and epileptic encephalopathy, highlighting its clinical significance in neurogenetic research (Gardella2019Phenotypic).

## Structure
The SCN8A gene encodes the Na v 1.6 sodium channel, a crucial component in neuronal excitability. The protein is composed of four homologous domains (DI-DIV), each containing six transmembrane segments (S1-S6). The S4 segment functions as a voltage sensor, while the S5 and S6 segments form the pore module, which is essential for ion conduction (Jiang2022Structural). The channel's structure includes a selectivity filter composed of specific amino acids that allow sodium ions to pass, contributing to its ion selectivity (Jiang2022Structural).

Na v 1.6 is characterized by its α1-β1 complex assembly, with associated lipids and glycosylation sites. A notable feature is the glycosylation at Asn326, which is conserved among Na v channels except Na v 1.7 and Na v 1.9. This glycosylation, along with interactions with aromatic residues, stabilizes the protein-glycan complex (Fan2023Cryo-EM). The intracellular gate of Na v 1.6 is penetrated by a glyco-diosgenin molecule, and the extracellular loop I is involved in association with the β1 subunit through a hydrogen bond network (Fan2023Cryo-EM).

Alternative splicing of SCN8A results in multiple isoforms, which can affect channel kinetics and expression (O’Brien2013Sodium). These structural features are critical for the channel's function and its role in neurological disorders.

## Function
The SCN8A gene encodes the sodium channel Nav1.6, which is crucial for the generation and propagation of action potentials in neurons. Nav1.6 is predominantly localized at nodes of Ranvier, dendrites, and synapses in both the central and peripheral nervous systems, playing a vital role in electrical conduction in myelinated and unmyelinated axons (Caldwell2000Sodium). This channel is essential for the rapid influx of sodium ions, contributing to neuronal excitability and communication. It is involved in the rising phase of action potentials, facilitating the propagation of electrical signals in neurons and muscle cells (Meisler2004Allelic).

Nav1.6 is highly expressed in cerebellar Purkinje cells, where it supports complex spiking activity crucial for motor control (Meisler2004Allelic). Its presence in both presynaptic and postsynaptic membranes suggests a role in synaptic plasticity and the regulation of synaptic vesicle release, influencing synaptic strength and integration (Caldwell2000Sodium). The channel's localization in dendritic shafts and its association with microtubules imply a role in the transport of vesicles containing the channel, further supporting its involvement in synaptic transmission and neuronal signaling (Caldwell2000Sodium).

## Clinical Significance
Mutations in the SCN8A gene, which encodes the sodium channel NaV1.6, are associated with a range of neurological disorders, primarily developmental and epileptic encephalopathy (DEE). These conditions are characterized by early-onset epilepsy, cognitive and motor regression, and other neurological symptoms such as ataxia and dyskinesia (Xiao2018Early-onset; Gardella2019Phenotypic). The phenotypic spectrum of SCN8A-related disorders includes severe DEE with intractable seizures, mild-to-moderate intellectual disability with treatable epilepsy, benign infantile seizures with normal cognition, and cognitive or behavioral disturbances without epilepsy (Gardella2019Phenotypic).

Most pathogenic variants in SCN8A are missense mutations that lead to gain-of-function effects, resulting in hyperactivity of the ion channel and neuronal hyperexcitability (Johannesen2021Genotypephenotype; Kim2019Genetic). These gain-of-function mutations are often associated with severe epilepsy, while loss-of-function variants are linked to intellectual disability and movement disorders without epilepsy (Blanchard2015De; Liu2019Neuronal). The SCN8A-related epilepsies typically follow an autosomal dominant inheritance pattern, with severe DEE cases usually being de novo mutations (Gardella2019Phenotypic). Treatment options vary, with sodium channel blockers being effective for seizure control in many cases (Kim2019Genetic).

## Interactions
The SCN8A gene encodes the Na v 1.6 sodium channel, which is involved in various protein interactions crucial for its localization and function in neurons. Na v 1.6 is highly concentrated at the axon initial segment (AIS) and nodes of Ranvier, where it interacts with Ankyrin G and MAP1B. Ankyrin G binds to a conserved motif in the intracellular loop of voltage-gated channels, which is essential for localizing Na v 1.6 to the AIS and nodes of Ranvier. MAP1B interacts with the cytoplasmic N-terminus of Na v 1.6, stabilizing it at the AIS by preventing rapid endocytosis (Meisler2021Sodium).

The C-terminal domain of Na v 1.6 also interacts with various regulatory proteins, including fibroblast growth factor homologous factors (FHFs), G-protein subunits, and the sodium channel subunit β1. These interactions are important for channel trafficking, expression, and gating. Mutations in SCN8A, such as p.Arg1872Trp, do not impair the binding of these regulatory proteins, indicating that the channel's functional alterations are due to other mechanisms (Wagnon2015Pathogenic; Pan2019Distinct). These interactions highlight the complex regulatory network that modulates Na v 1.6 activity and its role in neuronal excitability.


## References


[1. (O’Brien2013Sodium) Janelle E. O’Brien and Miriam H. Meisler. Sodium channel scn8a (nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Frontiers in Genetics, 2013. URL: http://dx.doi.org/10.3389/fgene.2013.00213, doi:10.3389/fgene.2013.00213. This article has 99 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2013.00213)

[2. (Xiao2018Early-onset) Yangyang Xiao, Jie Xiong, Ding’an Mao, Lingjuan Liu, Jian Li, Xingfang Li, Haiyan Luo, and Liqun Liu. Early-onset epileptic encephalopathy with de novo scn8a mutation. Epilepsy Research, 139:9–13, January 2018. URL: http://dx.doi.org/10.1016/j.eplepsyres.2017.10.017, doi:10.1016/j.eplepsyres.2017.10.017. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.eplepsyres.2017.10.017)

[3. (Pan2019Distinct) Yanling Pan and Theodore R. Cummins. Distinct functional alterations in scn8a epilepsy mutant channels. The Journal of Physiology, 598(2):381–401, December 2019. URL: http://dx.doi.org/10.1113/JP278952, doi:10.1113/jp278952. This article has 52 citations.](https://doi.org/10.1113/JP278952)

4. (Johannesen2021Genotypephenotype) Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. This article has 4 citations.

[5. (Kim2019Genetic) Hyo Jeong Kim, Donghwa Yang, Se Hee Kim, Borahm Kim, Heung Dong Kim, Joon Soo Lee, Jong Rak Choi, Seung-Tae Lee, and Hoon-Chul Kang. Genetic and clinical features of scn8a developmental and epileptic encephalopathy. Epilepsy Research, 158:106222, December 2019. URL: http://dx.doi.org/10.1016/j.eplepsyres.2019.106222, doi:10.1016/j.eplepsyres.2019.106222. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.eplepsyres.2019.106222)

[6. (Jiang2022Structural) Daohua Jiang, Jiangtao Zhang, and Zhanyi Xia. Structural advances in voltage-gated sodium channels. Frontiers in Pharmacology, June 2022. URL: http://dx.doi.org/10.3389/fphar.2022.908867, doi:10.3389/fphar.2022.908867. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.908867)

[7. (Meisler2021Sodium) Miriam H. Meisler, Sophie F. Hill, and Wenxi Yu. Sodium channelopathies in neurodevelopmental disorders. Nature Reviews Neuroscience, 22(3):152–166, February 2021. URL: http://dx.doi.org/10.1038/s41583-020-00418-4, doi:10.1038/s41583-020-00418-4. This article has 96 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41583-020-00418-4)

[8. (Wagnon2015Pathogenic) Jacy L. Wagnon, Bryan S. Barker, James A. Hounshell, Charlotte A. Haaxma, Amy Shealy, Timothy Moss, Sumit Parikh, Ricka D. Messer, Manoj K. Patel, and Miriam H. Meisler. Pathogenic mechanism of recurrent mutations of <scp>scn8a</scp> in epileptic encephalopathy. Annals of Clinical and Translational Neurology, 3(2):114–123, December 2015. URL: http://dx.doi.org/10.1002/acn3.276, doi:10.1002/acn3.276. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.276)

[9. (Caldwell2000Sodium) John H. Caldwell, Kristin L. Schaller, Robert S. Lasher, Elior Peles, and S. Rock Levinson. Sodium channel na v 1.6 is localized at nodes of ranvier, dendrites, and synapses. Proceedings of the National Academy of Sciences, 97(10):5616–5620, April 2000. URL: http://dx.doi.org/10.1073/pnas.090034797, doi:10.1073/pnas.090034797. This article has 524 citations.](https://doi.org/10.1073/pnas.090034797)

[10. (Meisler2004Allelic) Miriam H. Meisler, Nicholas W. Plummer, Daniel L. Burgess, David A. Buchner, and Leslie K. Sprunger. Allelic mutations of the sodium channel scn8a reveal multiple cellular and physiological functions. Genetica, 122(1):37–45, September 2004. URL: http://dx.doi.org/10.1007/s10709-004-1441-9, doi:10.1007/s10709-004-1441-9. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10709-004-1441-9)

[11. (Blanchard2015De) Maxime G Blanchard, Marjolein H Willemsen, Jaclyn B Walker, Sulayman D Dib-Hajj, Stephen G Waxman, Marjolijn CJ Jongmans, Tjitske Kleefstra, Bart P van de Warrenburg, Peter Praamstra, Joost Nicolai, Helger G Yntema, René JM Bindels, Miriam H Meisler, and Erik-Jan Kamsteeg. De novo gain-of-function and loss-of-function mutations ofscn8ain patients with intellectual disabilities and epilepsy. Journal of Medical Genetics, 52(5):330–337, February 2015. URL: http://dx.doi.org/10.1136/jmedgenet-2014-102813, doi:10.1136/jmedgenet-2014-102813. This article has 124 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2014-102813)

[12. (Liu2019Neuronal) Yuanyuan Liu, Julian Schubert, Lukas Sonnenberg, Katherine L Helbig, Christina E Hoei-Hansen, Mahmoud Koko, Maert Rannap, Stephan Lauxmann, Mahbubul Huq, Michael C Schneider, Katrine M Johannesen, Gerhard Kurlemann, Elena Gardella, Felicitas Becker, Yvonne G Weber, Jan Benda, Rikke S Møller, and Holger Lerche. Neuronal mechanisms of mutations in scn8a causing epilepsy or intellectual disability. Brain, 142(2):376–390, January 2019. URL: http://dx.doi.org/10.1093/brain/awy326, doi:10.1093/brain/awy326. This article has 102 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awy326)

[13. (Fan2023Cryo-EM) Xiao Fan, Jian Huang, Xueqin Jin, and Nieng Yan. Cryo-em structure of human voltage-gated sodium channel na v 1.6. Proceedings of the National Academy of Sciences, January 2023. URL: http://dx.doi.org/10.1073/pnas.2220578120, doi:10.1073/pnas.2220578120. This article has 20 citations.](https://doi.org/10.1073/pnas.2220578120)

[14. (Gardella2019Phenotypic) Elena Gardella and Rikke S. Møller. Phenotypic and genetic spectrum of <scp>scn</scp>8a‐related disorders, treatment options, and outcomes. Epilepsia, December 2019. URL: http://dx.doi.org/10.1111/epi.16319, doi:10.1111/epi.16319. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/epi.16319)